First-In-Human Study of Cemiplimab Alone or In Combination with Radiotherapy and/or Low-dose Cyclophosphamide in Patients with Advanced Malignancies.

Papadopoulos, Kyriakos P; Johnson, Melissa L; Lockhart, Albert C; Moore, Kathleen; Falchook, Gerald S; Formenti, Silvia C; Naing, Aung; Carvajal, Richard D; Rosen, Lee S; Weiss, Glen J; Leidner, Rom S; Li, Jingjin; Paccaly, Anne; Feng, Minjie; Stankevich, Elizabeth; Lowy, Israel; Fury, Matthew G; Crittenden, Marka R

Papadopoulos, Kyriakos P; Johnson, Melissa L; Lockhart, Albert C; Moore, Kathleen; Falchook, Gerald S; Formenti, Silvia C; Naing, Aung; Carvajal, Richard D; Rosen, Lee S; Weiss, Glen J; Leidner, Rom S; Li, Jingjin; Paccaly, Anne; Feng, Minjie; Stankevich, Elizabeth; Lowy, Israel; Fury, Matthew G; Crittenden, Marka R.

Affiliation

Papadopoulos KP; START, San Antonio, Texas. Kyri.Papadopoulos@startsa.com.
Johnson ML; Sarah Cannon Research Institute, Nashville, Tennessee.
Lockhart AC; Department of Medicine, Washington University in St. Louis, St. Louis, Missouri.
Moore K; Stephenson Cancer Center at the University of Oklahoma Health Sciences Center/Sarah Cannon Research Institute, Oklahoma City, Oklahoma.
Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, Colorado.
Formenti SC; Department of Radiation Oncology, Weill Cornell Medicine, New York, New York.
Naing A; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), The University of Texas MD Anderson Cancer Center, Houston, Texas.
Carvajal RD; Division of Hematology/Oncology, Columbia University Medical Center, New York, New York.
Rosen LS; UCLA Division of Hematology-Oncology, Santa Monica, California.
Weiss GJ; Western Regional Medical Center, Goodyear, Arizona.
Leidner RS; Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, Oregon.
Li J; Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey.
Paccaly A; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Feng M; Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey.
Stankevich E; Regeneron Pharmaceuticals, Inc., Basking Ridge, New Jersey.
Lowy I; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Fury MG; Regeneron Pharmaceuticals, Inc., Tarrytown, New York.
Crittenden MR; Earle A. Chiles Research Institute and The Oregon Clinic, Portland, Oregon.

Clin Cancer Res ; 26(5): 1025-1033, 2020 03 01.

Article de En | MEDLINE | ID: mdl-31796520

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Protocoles de polychimiothérapie antinéoplasique / Chimioradiothérapie / Évaluation de la réponse des tumeurs solides aux traitements / Tumeurs Type d'étude: Clinical_trials Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2020 Type de document: Article Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google